Kyohei Nakamura

300 Herston Road
Herston, QLD 4006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

NK cell heparanase controls tumor invasion and immune surveillance.

NK cell heparanase controls tumor invasion and immune surveillance.

Journal: The Journal of clinical investigation

Published: July 01, 2024

The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy.

The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy.

Journal: Immunology and cell biology

Published: May 20, 2024

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.

Journal: Nature immunology

Published: March 22, 2024

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Author Correction: The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation.

Journal: Nature immunology

Published: February 15, 2024

Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy.

Harnessing the cytotoxic granule exocytosis to augment the efficacy of T-cell-engaging bispecific antibody therapy.

Journal: Haematologica

Published: October 30, 2023

Regulatory T cells hamper the efficacy of T-cell-engaging bispecific antibody therapy.

Regulatory T cells hamper the efficacy of T-cell-engaging bispecific antibody therapy.

Journal: Haematologica

Published: June 14, 2023

Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.

Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphoma.

Journal: Leukemia

Published: September 30, 2022

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA.

Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA.

Journal: Blood advances

Published: May 17, 2022

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.

Journal: The Journal of clinical investigation

Published: March 15, 2022

Oncogenic drivers dictate immune control of acute myeloid leukemia.

Oncogenic drivers dictate immune control of acute myeloid leukemia.

Journal: Nature communications

Published: October 12, 2021

The immune microenvironment of multiple myeloma

The immune microenvironment of multiple myeloma

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 09, 2021

A simple organic solvent precipitation method to improve detection of low molecular weight proteins.

A simple organic solvent precipitation method to improve detection of low molecular weight proteins.

Journal: Proteomics

Published: June 21, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026